3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Exostoses, Multiple Hereditary
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Clinical Stage I Gastric Cancer AJCC v8
1
Breast Cancer Lymphedema
1
BTC
1
Interventions
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
Vincristine
3
Specimen Handling
3
Irinotecan
3
Cyclophosphamide
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
ensartinib
2
Temozolomide
2
Radiotherapy
2
temsirolimus
1
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
liposomal doxorubicin
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
erdafitinib
1
cabozantinib
1
atezolizumab
1
Vinorelbine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
Surgical Procedures, Operative
×
30 days
×
Clear all
No trials found.